Skip to main content
. 2021 Feb 8;11(2):238. doi: 10.3390/biom11020238

Figure 1.

Figure 1

A brief history of cellular immunotherapy development from bench to bedside. (A) The CAR-T therapies evolved from undefined targets/clinically effective, defined targets/clinically ineffective, to defined targets/clinically effective. (B) The schematic figures of TCR machinery, chimeric TCR machinery, and different generations of CAR-T with the use of scFv.